Citigroup’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$814K Sell
25,280
-3,477
-12% -$129K ﹤0.01% 3246
2025
Q4
$1.21M Sell
28,757
-1,425
-5% -$57.4K ﹤0.01% 3011
2025
Q3
$1.04M Sell
30,182
-48,731
-62% -$1.4M ﹤0.01% 3142
2025
Q2
$2.13M Sell
78,913
-75,718
-49% -$2.19M ﹤0.01% 2582
2025
Q1
$4.58M Buy
154,631
+51,810
+50% +$1.97M ﹤0.01% 1977
2024
Q4
$4.07M Buy
102,821
+42,044
+69% +$1.59M ﹤0.01% 2169
2024
Q3
$2.07M Buy
60,777
+28,082
+86% +$790K ﹤0.01% 2634
2024
Q2
$709K Sell
32,695
-240,713
-88% -$5.06M ﹤0.01% 3153
2024
Q1
$6.06M Buy
273,408
+196,832
+257% +$4.8M ﹤0.01% 1573
2023
Q4
$2.11M Sell
76,576
-18,390
-19% -$444K ﹤0.01% 2197
2023
Q3
$2.12M Buy
94,966
+316
+0.3% +$8.13K ﹤0.01% 1938
2023
Q2
$2.41M Sell
94,650
-144,514
-60% -$3.5M ﹤0.01% 2029
2023
Q1
$5.33M Buy
239,164
+109,680
+85% +$2.65M ﹤0.01% 1474
2022
Q4
$3.07M Sell
129,484
-191,716
-60% -$4.46M ﹤0.01% 1752
2022
Q3
$5.33M Buy
321,200
+107,552
+50% +$2.42M ﹤0.01% 1524
2022
Q2
$4.25M Buy
213,648
+163,273
+324% +$3.3M ﹤0.01% 1632
2022
Q1
$1.39M Sell
50,375
-80,229
-61% -$2.29M ﹤0.01% 2657
2021
Q4
$5.38M Buy
130,604
+56,607
+76% +$2.5M ﹤0.01% 1773
2021
Q3
$3.44M Sell
73,997
-64,012
-46% -$2.79M ﹤0.01% 2071
2021
Q2
$5.52M Buy
138,009
+51,650
+60% +$2.21M ﹤0.01% 1820
2021
Q1
$4.64M Buy
86,359
+69,665
+417% +$4.01M ﹤0.01% 1830
2020
Q4
$817K Buy
16,694
+7,950
+91% +$368K ﹤0.01% 3741
2020
Q3
$285K Sell
8,744
-65,840
-88% -$2.09M ﹤0.01% 4326
2020
Q2
$1.93M Buy
74,584
+30,178
+68% +$752K ﹤0.01% 2848
2020
Q1
$1.08M Sell
44,406
-10,357
-19% -$261K ﹤0.01% 3092
2019
Q4
$1.53M Sell
54,763
-13,248
-19% -$343K ﹤0.01% 3290
2019
Q3
$1.63M Sell
68,011
-23,766
-26% -$632K ﹤0.01% 3093
2019
Q2
$2.62M Buy
91,777
+84,284
+1,125% +$2.11M ﹤0.01% 2560
2019
Q1
$187K Buy
7,493
+563
+8% +$10.8K ﹤0.01% 5177
2018
Q4
$87K Sell
6,930
-691
-9% -$8.17K ﹤0.01% 5773
2018
Q3
$73K Buy
7,621
+5,148
+208% +$56.8K ﹤0.01% 6205
2018
Q2
$23K Sell
2,473
-649
-21% -$4.56K ﹤0.01% 6854
2018
Q1
$18K Sell
3,122
-339
-10% -$2.1K ﹤0.01% 6808
2017
Q4
$22K Buy
3,461
+3,389
+4,707% +$25.2K ﹤0.01% 6688
2017
Q3
$1K Sell
72
-181
-72% -$1.47K ﹤0.01% 7161
2017
Q2
$2K Sell
253
-12,274
-98% -$100K ﹤0.01% 7031
2017
Q1
$115K Sell
12,527
-199
-2% -$1.63K ﹤0.01% 5111
2016
Q4
$98K Buy
12,726
+8,576
+207% +$64.1K ﹤0.01% 5787
2016
Q3
$32K Buy
4,150
+1,150
+38% +$6.5K ﹤0.01% 5945
2016
Q2
$15K Sell
3,000
-9,465
-76% -$50.8K ﹤0.01% 6335
2016
Q1
$67K Buy
12,465
+12,064
+3,008% +$71.3K ﹤0.01% 5942
2015
Q4
$3K Sell
401
-606
-60% -$4.08K ﹤0.01% 7207
2015
Q3
$5K Buy
1,007
+432
+75% +$4.11K ﹤0.01% 6753
2015
Q2
$6K Buy
575
+218
+61% +$2.15K ﹤0.01% 6693
2015
Q1
$3K Sell
357
-1,239
-78% -$10.2K ﹤0.01% 6878
2014
Q4
$16K Sell
1,596
-61,749
-97% -$482K ﹤0.01% 6313
2014
Q3
$618K Buy
63,345
+29,370
+86% +$386K ﹤0.01% 3376
2014
Q2
$582K Buy
33,975
+28,601
+532% +$412K ﹤0.01% 3355
2014
Q1
$92K Buy
5,374
+2,936
+120% +$46.9K ﹤0.01% 5067
2013
Q4
$36K Buy
+2,438
New +$31.7K ﹤0.01% 5884

Other funds holding VCYT

Citigroup's VCYT Position: Q1 2026 in Review

Citigroup reduced its Veracyte (VCYT) stake by 12% in Q1 2026, selling an estimated $129K and leaving 25,280 shares worth $814K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

Citigroup first reported a position in VCYT in Q4 2013 and has held it in 50 quarters since. The position peaked at $6.06M in Q1 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Citigroup held 25,280 shares of Veracyte worth $814K as of Q1 2026.
  • Citigroup sold 3,477 Veracyte shares in Q1 2026, an estimated $129K.
  • Veracyte made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3246 holding.
  • Citigroup first reported a position in Veracyte in Q4 2013 and has held it in 50 quarters since.
  • Citigroup's Veracyte position peaked at $6.06M in Q1 2024.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.